Federal award (PURCHASE ORDER, fiscal year 2023)
Recipient: RLS (USA) INC.
Awarding agency: Department of Defense / Defense Health Agency
Funding agency: Department of Defense / Defense Health Agency
Period of performance: 2022-05-11 to 2024-05-31
Current total value of award: $33890.92
Description: RADIOPHARMACEUTICALS